InsiderPulse
Dashboard

MEDP

Medpace Holdings, Inc.

Health CareRussell 2000

Medpace Holdings, Inc. insider trading

Medpace Holdings, Inc. files with the SEC as a Services-Commercial Physical & Biological Research company headquartered in Cincinnati, OH. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent MEDP insider transactions

8 insiders traded MEDP on the open market between May 28, 2026 and Sep 17, 2026 — 24 sales worth $112.1M.

Bought
—
Sold
$112.1M

none on a 10b5-1 plan

Net
−$112.1M
Insiders
8

Open-market purchases (code P) and sales (code S) from Medpace Holdings, Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 22, 2026. The live dashboard shows new filings the moment they clear.

Every MEDP Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

MEDP insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded MEDP on the open market: 1 purchase worth $652 and 41 sales worth $338.3M, 1 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 37 sales ($333.2M), by 8 insiders.

QuarterBoughtSold
Q2 2026—−$7.4M1 sale
Q1 2026—−$14.4M1 sale
Q4 2025—−$236.8M25 sales · 1 on a plan
Q3 2025—−$74.7M10 sales
Q2 2025—−$516.7K1 sale
Q1 2025+$6521 buy−$1.4M1 sale
Q4 2024——
Q3 2024—−$3.2M2 sales
Largest purchase
+$652 of MEDP by Ewald Stephen P (General Counsel & Corp. Secy.) on Feb 27, 2025.
Largest sale
−$35.9M of MEDP by Troendle August J. (CEO · Director) on Nov 24, 2025.

Open-market transactions through Jun 30, 2026most recent first

  • Geiger Jesse J

    President

    −$14.4M

    Mar 17, 2026

    31,707 sh · $455.30

  • Troendle August J.

    CEO · Director

    −$394.6K

    Dec 03, 2025

    668 sh · $590.69

  • Troendle August J.

    CEO · Director

    −$3.4M

    Dec 02, 2025

    5,698 sh · $590.47

  • Troendle August J.

    CEO · Director

    −$13.8M

    Dec 01, 2025

    23,178 sh · $593.25

  • Troendle August J.

    CEO · Director

    −$9M

    Nov 28, 2025

    15,151 sh · $593.46

  • Troendle August J.

    CEO · Director

    −$25.1M

    Nov 26, 2025

    41,331 sh · $606.88

  • Troendle August J.

    CEO · Director

    −$26.1M

    Nov 25, 2025

    42,392 sh · $615.52

  • Troendle August J.

    CEO · Director

    −$35.9M

    Nov 24, 2025

    59,025 sh · $607.78

  • Burwig Susan E

    Exec. VP, Operations

    −$12.2M

    Nov 24, 2025

    20,000 sh · $609.15

  • Troendle August J.

    CEO · Director

    −$12.9M

    Nov 21, 2025

    21,858 sh · $592.18

  • Brady Kevin M.

    CFO & Treasurer

    −$1.8M

    Nov 21, 2025

    3,000 sh · $590.35

  • Troendle August J.

    CEO · Director

    −$4.1M

    Nov 20, 2025

    6,830 sh · $598.49

  • Troendle August J.

    CEO · Director

    −$14.1M

    Nov 19, 2025

    23,862 sh · $592.07

  • Troendle August J.

    CEO · Director

    −$4.2M

    Nov 18, 2025

    7,191 sh · $590.84

  • Troendle August J.

    CEO · Director

    −$3.6M

    Nov 17, 2025

    6,047 sh · $591.00

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Medpace Holdings, Inc. company record

SEC industry classification
Services-Commercial Physical & Biological Research
Headquarters
Cincinnati, OH
Incorporated in
DE
Listed on
Nasdaq
SEC Central Index Key
0001668397

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought MEDP

What the stock actually did in the 90 days following each open-market purchase

Don't check MEDP — let it ping you

Get told the moment an insider moves on MEDP

Pro watches Medpace Holdings, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add MEDP to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track MEDP on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read MEDP insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

DNLIVEEVTEMALKSAPLSARVNBBIOCYTKDAWNDYNIMVTINSM
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are MEDP insiders buying or selling?
Between May 28, 2026 and Sep 17, 2026, 8 Medpace Holdings, Inc. insiders made no open-market purchases and 24 sales worth $112.1M, a net sale of $112.1M.
How much MEDP stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 9 Medpace Holdings, Inc. insiders made 1 open-market purchase worth $652 and 41 sales worth $338.3M. 1 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 37 sales ($333.2M). The largest purchase was Ewald Stephen P buying $652 on Feb 27, 2025. The largest sale was Troendle August J. selling $35.9M on Nov 24, 2025.
What was the largest recent MEDP insider trade?
Troendle August J. (President & CEO · Director) sold $16.8M of MEDP stock on Aug 20, 2026 at about $618.79 a share.
When did an insider last buy MEDP shares?
No open-market purchase by a Medpace Holdings, Inc. insider appears in the filings from May 28, 2026 to Sep 17, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Ewald Stephen P buying $652 on Feb 27, 2025.
Where does MEDP insider trading data come from?
From the Form 4 filings Medpace Holdings, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.